CRISPR trial for inherited blindness underway
Editas Medicine and Allergan are teaming up to conduct the first human trial of a CRISPR gene-editing therapy for inherited blindness. Source: AAO
- Posted on: Aug 1 2019
- Leave a response
Editas Medicine and Allergan are teaming up to conduct the first human trial of a CRISPR gene-editing therapy for inherited blindness. Source: AAO
The authors describe a new technique called transzonular capsulo-hyaloidal hydroseparation to detect or induce anterior hyaloid membrane detachment for primary posterior laser capsulotomy. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »